| 7764-4 |
Walnut black western Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Black Western Walnut IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7764-4 |
|
|
|
|
Both |
|
|
|
0 |
Black West Walnut IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Black West Walnut; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; West |
2.42 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 77640-1 |
HLA class I & II Ab.IgG |
Imp |
Ser/Plas |
Pt |
Nar |
IA |
|
ACTIVE |
HLA class I and II IgG Ab in Serum or Plasma by Immunoassay [interpretation] Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
77640-1 |
|
IA |
|
|
Observation |
|
|
|
0 |
HLA class I + II IgG SerPl IA-Imp |
|
|
|
|
|
2; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; HLA class I + II; Human Leukocyte Antigen; IAA; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MEIA; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.56 |
2.52 |
|
|
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 77641-9 |
HLA-A Ab.IgG |
Prid |
Ser/Plas |
Pt |
Nom |
IA |
|
ACTIVE |
HLA-A IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
77641-9 |
|
IA |
|
|
Both |
|
|
|
0 |
HLA-A IgG SerPl IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; Human Leukocyte Antigen; IAA; Identity or presence; Immune globulin G; Immunoglobulin G; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.56 |
2.52 |
|
|
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 77642-7 |
HLA-B Ab.IgG |
Prid |
Ser/Plas |
Pt |
Nom |
IA |
|
ACTIVE |
HLA-B IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
77642-7 |
|
IA |
|
|
Both |
|
|
|
0 |
HLA-B IgG SerPl IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; Human Leukocyte Antigen; IAA; Identity or presence; Immune globulin G; Immunoglobulin G; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.56 |
2.52 |
|
|
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 77643-5 |
HLA-C Ab.IgG |
Prid |
Ser/Plas |
Pt |
Nom |
IA |
|
ACTIVE |
HLA-C IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
77643-5 |
|
IA |
|
|
Both |
|
|
|
0 |
HLA-C IgG SerPl IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; Human Leukocyte Antigen; IAA; Identity or presence; Immune globulin G; Immunoglobulin G; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; Rh Blood Group System; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.56 |
2.52 |
|
|
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 77644-3 |
HLA-DP Ab.IgG |
Prid |
Ser/Plas |
Pt |
Nom |
IA |
|
ACTIVE |
HLA-DP IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
77644-3 |
|
IA |
|
|
Both |
|
|
|
0 |
HLA-DP IgG SerPl IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; Human Leukocyte Antigen; IAA; Identity or presence; Immune globulin G; Immunoglobulin G; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.56 |
2.52 |
|
|
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 77645-0 |
HLA-DQ Ab.IgG |
Prid |
Ser/Plas |
Pt |
Nom |
IA |
|
ACTIVE |
HLA-DQ IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
77645-0 |
|
IA |
|
|
Both |
|
|
|
0 |
HLA-DQ IgG SerPl IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; IAA; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.56 |
2.52 |
|
|
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 77646-8 |
HLA-DR Ab.IgG |
Prid |
Ser/Plas |
Pt |
Nom |
IA |
|
ACTIVE |
HLA-DR IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
77646-8 |
|
IA |
|
|
Both |
|
|
|
0 |
HLA-DR IgG SerPl IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; Human Leukocyte Antigen; I3; IAA; Identity or presence; Immune globulin G; Immunoglobulin G; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.56 |
2.52 |
|
|
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 77647-6 |
Animal compounded drug label |
- |
^FDA product label |
- |
Nar |
|
|
ACTIVE |
FDA product label Animal compounded drug label |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOCUMENT.REGULATORY |
|
77647-6 |
|
|
|
|
Both |
|
|
|
0 |
FDA label Animal compded drug label |
|
|
|
|
|
Animal compded drug label; DOCUMENT.REGULATORY; Drugs; FDA label; Narrative; Report |
2.52 |
2.52 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 77648-4 |
Indexing - biologic or drug substance |
- |
^FDA product label |
- |
Nar |
|
|
ACTIVE |
FDA product label Indexing - biologic or drug substance |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOCUMENT.REGULATORY |
|
77648-4 |
|
|
|
|
Both |
|
|
|
0 |
FDA label Index - biol or drug subst |
|
|
|
|
|
DOCUMENT.REGULATORY; Drugs; FDA label; Index - biol or drug subst; Narrative; Report; Subs |
2.52 |
2.52 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 77649-2 |
17-Hydroxyprogesterone^10M post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
77649-2 |
|
|
|
|
Observation |
|
|
|
0 |
17OHP 10M p chal SerPl-sCnc |
|
|
|
|
|
10M p chal; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Hydroxyproges; Hydroxyprogstron; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.52 |
2.52 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 7765-1 |
Juglans regia Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
English Walnut IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7765-1 |
|
|
|
|
Both |
|
|
|
0 |
English Walnut IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; English walnut; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 77650-0 |
17-Hydroxyprogesterone^15M post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
77650-0 |
|
|
|
|
Observation |
|
|
|
0 |
17OHP 15M p chal SerPl-sCnc |
|
|
|
|
|
15M p chal; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Hydroxyproges; Hydroxyprogstron; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.52 |
2.52 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 77651-8 |
C peptide^75M post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
77651-8 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 75M p chal SerPl-sCnc |
|
|
|
|
|
75M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.52 |
2.52 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 77652-6 |
C peptide^5H post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
77652-6 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 5h p chal SerPl-sCnc |
|
|
|
|
|
5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.52 |
2.52 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 77653-4 |
Observation |
Prid |
Anorectal |
Pt |
Nom |
Cyto stain.thin prep |
|
ACTIVE |
Microscopic observation [Identifier] in Anorectal Cyto stain.thin prep |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CYTO |
|
77653-4 |
|
Cyto stain.thin prep |
|
|
Both |
|
|
|
0 |
Thin Prep Anorectl |
|
|
|
|
|
Anorectl; CYTOLOGY; Cytology stain; Cytostain; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; Rectum; St; Stains; Stn |
2.78 |
2.52 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Updated to seperate the component from the method; |
0 |
| 77654-2 |
Cells.diploid.G2 phase/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Diploid cells in G2 phase/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77654-2 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Dipl cells in G2 NFr Cells.XXX FC |
|
|
|
|
|
Cell; Cellularity; Dipl cells; Dipl cells in G2; Dynamic; FC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 77655-9 |
Cells.diploid/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Diploid cells/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77655-9 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Dipl cells NFr Cells.XXX FC |
|
|
|
|
|
Cell; Cellularity; Dipl cells; Dynamic; FC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 77656-7 |
Cells.diploid.S phase/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Diploid cells in S phase/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77656-7 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Dipl cells in S NFr Cells.XXX FC |
|
|
|
|
|
Cell; Cellularity; Dipl cells; Dipl cells in S; Dynamic; FC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 77657-5 |
Cells.diploid.G1 phase/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Diploid cells in G1 phase/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77657-5 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Dipl cells in G1 NFr Cells.XXX FC |
|
|
|
|
|
Cell; Cellularity; Dipl cells; Dipl cells in G1; Dynamic; FC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 77658-3 |
Cells.aneuploid.G2 phase population/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Aneuploid cell population in G2 phase/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77658-3 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Aneu cell pop in G2 NFr Cells.XXX FC |
|
|
|
|
|
Aneu cell pop in G2; Aneuploid Cells; Cell; Cellularity; Dynamic; FC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 77659-1 |
Cells.aneuploid.S phase population/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Aneuploid cell population in S phase/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77659-1 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Aneu cell pop in S NFr Cells.XXX FC |
|
|
|
|
|
Aneu cell pop in S; Aneuploid Cells; Cell; Cellularity; Dynamic; FC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 7766-9 |
Juglans regia pollen Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
English Walnut Pollen IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7766-9 |
|
|
|
|
Both |
|
|
|
0 |
Eng Walnut Poln IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Eng Walnut Poln; English Walnut; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.42 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 77660-9 |
Cells.aneuploid.G2 phase population 2/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Aneuploid cell population 2 in G2 phase/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77660-9 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Aneu cell pop 2 in G2 NFr Cells.XXX FC |
|
|
|
|
|
Aneu cell pop 2 in G2; Aneu cell pop in G2; Aneuploid Cells; Cell; Cellularity; Dynamic; FC; II; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 77661-7 |
Cells.aneuploid.S phase population 2/Cells |
NFr |
Cells.XXX |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Aneuploid cell population 2 in S phase/cells in Cells.XXX by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
77661-7 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Aneu cells pop 2 in S NFr Cells.XXX FC |
|
|
|
|
|
Aneu cell pop in S; Aneu cells pop 2 in S; Aneuploid Cells; Cell; Cellularity; Dynamic; FC; II; Misc; Miscellaneous; Molecular pathology; MOLPATH; Number Fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.52 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
